Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

R M Sharkey; T M Behr; M J Mattes; R Stein; G L Griffiths; L B Shih; H J Hansen; R D Blumenthal; R M Dunn; M E Juweid

doi:10.1007/s002620050371

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

Identifier:nobleid.org/w1/20260515/E568B686

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E568B686.svg?ark=w1%2F20260515%2FE568B686)](https://nobleid.org/work/w1/20260515/E568B686)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

Identifier:nobleid.org/w1/20260515/E568B686

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E568B686.svg?ark=w1%2F20260515%2FE568B686)](https://nobleid.org/work/w1/20260515/E568B686)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work